Prestige Consumer Healthcare Inc
NYSE:PBH

Watchlist Manager
Prestige Consumer Healthcare Inc Logo
Prestige Consumer Healthcare Inc
NYSE:PBH
Watchlist
Price: 82.12 USD 1.75% Market Closed
Market Cap: 4.1B USD

Prestige Consumer Healthcare Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Prestige Consumer Healthcare Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Prestige Consumer Healthcare Inc
NYSE:PBH
Revenue
$1.1B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
5%
Johnson & Johnson
NYSE:JNJ
Revenue
$88.8B
CAGR 3-Years
4%
CAGR 5-Years
2%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Revenue
$48.3B
CAGR 3-Years
1%
CAGR 5-Years
13%
CAGR 10-Years
12%
Pfizer Inc
NYSE:PFE
Revenue
$63.6B
CAGR 3-Years
-8%
CAGR 5-Years
9%
CAGR 10-Years
3%
Merck & Co Inc
NYSE:MRK
Revenue
$64.2B
CAGR 3-Years
10%
CAGR 5-Years
10%
CAGR 10-Years
4%
Eli Lilly and Co
NYSE:LLY
Revenue
$45B
CAGR 3-Years
17%
CAGR 5-Years
15%
CAGR 10-Years
9%

Prestige Consumer Healthcare Inc
Revenue Breakdown

Breakdown by Geography
Prestige Consumer Healthcare Inc

Total Revenue: 1.1B USD
100%
United States: 886.5m USD
78.8%
Rest Of World: 238.9m USD
21.2%

Breakdown by Segments
Prestige Consumer Healthcare Inc

Total Revenue: 1.1B USD
100%
Net Sales: 1.1B USD
100%
North American Otc Healthcare: 958.3m USD
85.2%
Women's Health: 240.4m USD
21.4%
Gastrointestinal: 231.6m USD
20.6%
Eye & Ear Care: 179.4m USD
15.9%
International Otc Healthcare: 167.1m USD
14.8%
Dermatologicals: 129.1m USD
11.5%
Cough & Cold: 119m USD
10.6%
Analgesics: 117.5m USD
10.4%
Oral Care: 96.3m USD
8.6%
Other Otc: 12m USD
1.1%
Other Revenues: 311k USD
0%
Show More

Prestige Consumer Healthcare Inc
Glance View

Market Cap
4.1B USD
Industry
Pharmaceuticals

Prestige Consumer Healthcare Inc. has carved out its niche in the competitive realm of over-the-counter healthcare products with a distinct flair. Born out of a series of insightful acquisitions and strategic brand cultivations, the company has crafted a portfolio that caters to a broad spectrum of consumer health needs. It offers an expansive range of products, from well-known pain relievers and eye care items to gastrointestinal treatments and women’s health solutions. The cornerstone of Prestige's success lies in its acute understanding of consumer demand and its agile response to market trends. By developing and acquiring brands that are established household names—such as Clear Eyes, Chloraseptic, and Dramamine—the firm has effectively secured a reliable revenue stream. Each brand, while under the corporate umbrella of Prestige, thrives on its ability to resonate with consumers who seek trustworthy, easily accessible remedies. Central to Prestige’s business model is its adeptness at maintaining and enhancing brand equity. Through a blend of focused marketing strategies and disciplined cost management, the company ensures consistent visibility and availability of its products across key retail channels, including mass merchandisers, drug retailers, and e-commerce. Prestige's skillful navigation of the marketplace allows it to capitalize on scale economies and maintain healthy margins. Each product in its portfolio is not only a testament to its commitment to quality and efficacy but also to its strategic foresight in addressing the ever-evolving healthcare challenges faced by consumers. In essence, Prestige Consumer Healthcare Inc. thrives by blending astute brand management with a keen focus on consumer health trends, ensuring its position as a formidable player in the healthcare industry.

PBH Intrinsic Value
74.19 USD
Overvaluation 10%
Intrinsic Value
Price

See Also

What is Prestige Consumer Healthcare Inc's Revenue?
Revenue
1.1B USD

Based on the financial report for Dec 31, 2024, Prestige Consumer Healthcare Inc's Revenue amounts to 1.1B USD.

What is Prestige Consumer Healthcare Inc's Revenue growth rate?
Revenue CAGR 10Y
5%

Over the last year, the Revenue growth was -1%. The average annual Revenue growth rates for Prestige Consumer Healthcare Inc have been 2% over the past three years , 3% over the past five years , and 5% over the past ten years .

Back to Top